• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄和疾病持续时间与共病和残疾的关系:瑞士多发性硬化症登记处的一项研究。

Association of age and disease duration with comorbidities and disability: A study of the Swiss Multiple Sclerosis Registry.

机构信息

Epidemiology, Biostatistics and Prevention Institute, University of Zurich (UZH), Hirschengraben 84, Zurich 8001, Switzerland; Institute for Implementation Science in Health Care, University of Zurich (UZH), Universitätstrasse 84, Zurich 8006, Switzerland.

Department of Neurology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland.

出版信息

Mult Scler Relat Disord. 2022 Nov;67:104084. doi: 10.1016/j.msard.2022.104084. Epub 2022 Jul 30.

DOI:10.1016/j.msard.2022.104084
PMID:35933756
Abstract

BACKGROUND

While comorbidities increase with age, duration of multiple sclerosis (MS) leads to disability accumulation in persons with MS. The influence of ageing vis-a-vis MS duration remains largely unexplored. We studied the independent associations of ageing and MS duration with disability and comorbidities in the Swiss MS Registry participants.

METHODS

Self-reported data was cross-sectionally analyzed using confounder-adjusted logistic regression models for 6 outcomes: cancer, type 2 diabetes (T2D), hypertension, cardiac diseases, depression, and having at least moderate or severe gait disability. Using cubic splines, we explored non-linear changes in risk shapes.

RESULTS

Among 1615 participants age was associated with cardiac diseases (OR 1.05, 95% CI [1.02, 2.08]), hypertension (OR 1.08, 95% CI [1.06, 2.10]), T2D (OR 1.10, 95%CI [1.05, 1.16]) and cancer (OR 1.04, 95% CI [1.01, 1.07]). MS duration was not associated with comorbidities, except for cardiac diseases (OR 1.03, 95% CI [1.00, 1.06]). MS duration and age were independently associated with having at least moderate gait disability (OR 1.06, 95% CI [1.04, 1.07]; OR 1.04, 95% CI [1.02, 1.05], respectively), and MS duration was associated with severe gait disability (OR 1.05, 95% CI [1.03, 1.08]). The spline analysis suggested a non-linear increase of having at least moderate gait disability with age.

CONCLUSIONS

Presence of comorbidities was largely associated with age only. Having at least moderate gait disability was associated with both age and MS duration, while having severe gait disabity was associated with MS duration only.

摘要

背景

随着年龄的增长,合并症会增加,而多发性硬化症(MS)的病程会导致 MS 患者的残疾积累。年龄与 MS 病程对残疾和合并症的影响在很大程度上仍未得到探索。我们在瑞士 MS 登记处参与者中研究了年龄和 MS 病程与残疾和合并症的独立关联。

方法

使用混杂因素调整的逻辑回归模型,对 6 项结果进行了横断面分析:癌症、2 型糖尿病(T2D)、高血压、心脏病、抑郁症和至少中度或重度步态残疾。使用三次样条,我们探索了风险形状的非线性变化。

结果

在 1615 名参与者中,年龄与心脏病(OR 1.05,95%CI [1.02,2.08])、高血压(OR 1.08,95%CI [1.06,2.10])、T2D(OR 1.10,95%CI [1.05,1.16])和癌症(OR 1.04,95%CI [1.01,1.07])有关。MS 病程与合并症无关,但与心脏病有关(OR 1.03,95%CI [1.00,1.06])。MS 病程和年龄与至少中度步态残疾独立相关(OR 1.06,95%CI [1.04,1.07];OR 1.04,95%CI [1.02,1.05]),MS 病程与严重步态残疾相关(OR 1.05,95%CI [1.03,1.08])。样条分析表明,年龄与至少中度步态残疾的增加呈非线性关系。

结论

合并症的存在主要与年龄有关。至少中度步态残疾与年龄和 MS 病程有关,而严重步态残疾仅与 MS 病程有关。

相似文献

1
Association of age and disease duration with comorbidities and disability: A study of the Swiss Multiple Sclerosis Registry.年龄和疾病持续时间与共病和残疾的关系:瑞士多发性硬化症登记处的一项研究。
Mult Scler Relat Disord. 2022 Nov;67:104084. doi: 10.1016/j.msard.2022.104084. Epub 2022 Jul 30.
2
Prevalence of comorbidities in Multiple Sclerosis and impact on physical disability according to disease phenotypes.多发性硬化症中共病的患病率及其根据疾病表型对身体残疾的影响。
Mult Scler Relat Disord. 2020 Nov;46:102565. doi: 10.1016/j.msard.2020.102565. Epub 2020 Oct 5.
3
The prevalence of comorbidities in patients with multiple sclerosis: population-based registry data.多发性硬化症患者共病的患病率:基于人群的登记数据。
Neurol Sci. 2021 May;42(5):1887-1893. doi: 10.1007/s10072-020-04727-5. Epub 2020 Sep 22.
4
Substantial adverse association of visual and vascular comorbidities on visual disability in multiple sclerosis.视觉和血管合并症与多发性硬化症患者视力障碍的显著不良关联。
Mult Scler. 2011 Dec;17(12):1464-71. doi: 10.1177/1352458511414041. Epub 2011 Aug 15.
5
Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis.血管合并症与多发性硬化症中更快的残疾进展有关。
Neurology. 2010 Mar 30;74(13):1041-7. doi: 10.1212/WNL.0b013e3181d6b125.
6
Comorbidity in multiple sclerosis: Emphasis on patient-reported outcomes.多发性硬化症中的共病现象:关注患者报告结局。
Mult Scler Relat Disord. 2022 Mar;59:103558. doi: 10.1016/j.msard.2022.103558. Epub 2022 Jan 31.
7
Impact of comorbidities on the disability progression in multiple sclerosis.合并症对多发性硬化症残疾进展的影响。
Acta Neurol Scand. 2022 Jan;145(1):24-29. doi: 10.1111/ane.13516. Epub 2021 Aug 20.
8
Frequency of Comorbidities and Their Association with Clinical Disability and Relapse in Multiple Sclerosis.多发性硬化症共病的频率及其与临床残疾和复发的关系。
Neuroepidemiology. 2016;46(2):106-13. doi: 10.1159/000442203. Epub 2016 Jan 20.
9
Perceived health- related quality of life in persons with multiple sclerosis with and without a vascular comorbidity.多发性硬化症伴或不伴血管合并症患者的健康相关生活质量感知。
Qual Life Res. 2024 Feb;33(2):573-581. doi: 10.1007/s11136-023-03546-3. Epub 2023 Nov 15.
10
Comorbidity, socioeconomic status and multiple sclerosis.共病、社会经济地位与多发性硬化症
Mult Scler. 2008 Sep;14(8):1091-8. doi: 10.1177/1352458508092263.

引用本文的文献

1
Effectiveness of Disease-Modifying Therapies in Patients With Late-Onset Relapsing-Remitting Multiple Sclerosis.疾病修饰疗法对晚发型复发缓解型多发性硬化症患者的疗效
Neurology. 2025 Aug 26;105(4):e213967. doi: 10.1212/WNL.0000000000213967. Epub 2025 Aug 7.
2
Role of Immune Reconstitution Therapy with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in Older Patients.克拉屈滨片免疫重建疗法在老年复发型多发性硬化症治疗中的作用
Neurol Ther. 2025 May 17. doi: 10.1007/s40120-025-00767-1.
3
Aging and the neuropsychiatry of multiple sclerosis: a cross-sectional study.
衰老与多发性硬化症的神经精神病学:一项横断面研究。
J Neurol. 2025 May 4;272(5):375. doi: 10.1007/s00415-025-13116-x.
4
The Prevalence of Comorbidities and Their Association With Disability Progression in Individuals With Multiple Sclerosis: A Study From Brazil.多发性硬化症患者共病的患病率及其与残疾进展的关联:一项来自巴西的研究。
Int J MS Care. 2024 Mar 9;26(Q3):239-246. doi: 10.7224/1537-2073.2023-103. eCollection 2024 May.
5
The Prevalence of Diabetes Mellitus Type II (DMII) in the Multiple Sclerosis Population: A Systematic Review and Meta-Analysis.多发性硬化症人群中2型糖尿病(DMII)的患病率:一项系统评价和荟萃分析。
J Clin Med. 2023 Jul 27;12(15):4948. doi: 10.3390/jcm12154948.